Scilex Holding (SCLX) Minority Interest (2025 - 2026)

Scilex Holding (SCLX) posted quarterly Minority Interest of -$4.9 million for Q1 2026, down 22.16% on a QoQ basis from -$4.0 million in Q4 2025.

Scilex Holding (SCLX) Minority Interest (2025 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Minority Interest for 2 consecutive years, with -$4.9 million the latest figure, recorded in Q1 2026.

In Q1 2026, Minority Interest changed N/A year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$4.9 million (changed N/A YoY), while the FY2025 annual figure was -$4.0 million, changed N/A from the prior year.
Minority Interest came in at -$4.9 million for Q1 2026 at Scilex Holding, down from -$4.0 million in the prior quarter.
The five-year high for Minority Interest was -$2.8 million in Q3 2025, with the low at -$4.9 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Scilex Holding	54.30 Mn	-95.62 Mn	4.15 Mn

Download Data